Rachel Smith | Executive Director, Global Head of Rare Disease, CoE
Parexel
Appearances:
Day 1 - Wednesday 28 October @ 16:10
Sustainability of lifetime dosing for antisense oligonucleotides in rare diseases: The need for scalable national models
last published: 14/Jul/25 09:35 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events